EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Reduced Ropivacaine Volume with Perineural Dexamethasone in PENG Block for Total Hip Arthroplasty: A Randomized Controlled Trial

Tomasz Reysner iD, Agnieszka Neumann-Podczaska iD, Pawel Pietraszek iD, Aleksander Mularski iD, Grzegorz Kowalski iD, Przemyslaw Daroszewski iD, Malgorzata Reysner iD

Journal of Clinical Medicine · 09.12.2025 · 14 (24) · 8722

DOI: 10.3390/jcm14248722 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.12.2025. Verfasst von Tomasz Reysner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Medicine, Poznan University of Medical Sciences, Os. Rusa 55, 61-245 Poznań, Poland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The pericapsular nerve group (PENG) block is increasingly used as part of multimodal analgesia for total hip arthroplasty (THA). However, standard high-volume local anesthetic regimens may impair motor function. The addition of perineural dexamethasone could allow for volume reduction while maintaining analgesic efficacy and minimizing quadriceps weakness. This study evaluated whether adding dexamethasone to a low-volume PENG block prolongs analgesia, reduces opioid consumption, maintains pain control, and preserves motor function compared to a standard-volume PENG block. Materials and Methods: In this randomized controlled trial (NCT06470334), 60 adult patients undergoing THA via the direct superior approach received either a standard-volume PENG block with 20 mL of 0.2% ropivacaine (PENG group) or a low-volume block with 10 mL of 0.2% ropivacaine plus 4 mg of perineural dexamethasone (PENG + DEX group). The primary outcome was time to first rescue opioid. Secondary outcomes included total 48-h opioid consumption (oral morphine equivalents), pain scores (numeric rating scale, NRS) at rest and during movement, and quadriceps muscle strength at predefined postoperative intervals.

Results

The PENG + DEX group demonstrated a significantly longer time to first opioid administration (15.0 ± 1.5 h vs. 9.1 ± 1.7 h; p < 0.0001) and reduced total opioid consumption within 48 h (2.3 ± 3.1 mEQ vs. 5.0 ± 4.4 mEQ; p = 0.0120). Pain scores were similar at 4 h but significantly lower in the PENG + DEX group at 8, 12, and 24 h postoperatively (all p < 0.01). Quadriceps strength was fully preserved in both groups at all assessed timepoints (p > 0.9999).

Conclusions

The addition of perineural dexamethasone to a low-volume PENG block provides longer-lasting analgesia and reduces opioid requirements without compromising pain control or quadriceps function. This approach may improve the safety and efficacy of regional anesthesia in THA.

Schlagwörter

Stichwörter der Autor:innen

elderly patientslow-volume local anestheticmotor-sparing regional anesthesiaopioid-sparing analgesiapericapsular nerve group block (PENG)perineural dexamethasonequadriceps strengthrandomized controlled trialropivacainetotal hip arthroplasty

Autor:innen und Institutionen

  • Department of Palliative Medicine, Poznan University of Medical Sciences, Os. Rusa 55, 61-245 Poznań, Poland.
  • Senior Institute, Department of Medical and Health Sciences, Vizja University, 01-043 Warsaw, Poland.
  • Department of Anesthesiology and Intensive Care, Poznan University of Medical Sciences, 61-245 Poznań, Poland.
  • Department of Forensic Medicine, Institute of Medical Sciences Collegium Medicum, University of Zielona Góra, 65-516 Zielona Góra, Poland.
  • Department of Organization and Management in Health Care, Poznan University of Medical Sciences, 61-245 Poznań, Poland.

ORCID-Profile: Tomasz Reysner, Agnieszka Neumann-Podczaska, Pawel Pietraszek, Aleksander Mularski, Grzegorz Kowalski, Przemyslaw Daroszewski, Malgorzata Reysner

Zitieren

APA

Reysner, T., Neumann-Podczaska, A., Pietraszek, P., Mularski, A., Kowalski, G., Daroszewski, P., & Reysner, M. (2025). Reduced Ropivacaine Volume with Perineural Dexamethasone in PENG Block for Total Hip Arthroplasty: A Randomized Controlled Trial. Journal of Clinical Medicine, 14(24), 8722. https://doi.org/10.3390/jcm14248722

Vancouver

Reysner T, Neumann-Podczaska A, Pietraszek P, Mularski A, Kowalski G, Daroszewski P, et al. Reduced Ropivacaine Volume with Perineural Dexamethasone in PENG Block for Total Hip Arthroplasty: A Randomized Controlled Trial. Journal of Clinical Medicine. 2025;14(24):8722. doi:10.3390/jcm14248722

BibTeX
@article{Reysner2025,
  author = {Reysner, Tomasz and Neumann-Podczaska, Agnieszka and Pietraszek, Pawel and Mularski, Aleksander and Kowalski, Grzegorz and Daroszewski, Przemyslaw and Reysner, Malgorzata},
  title = {Reduced Ropivacaine Volume with Perineural Dexamethasone in PENG Block for Total Hip Arthroplasty: A Randomized Controlled Trial},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {24},
  pages = {8722},
  doi = {10.3390/jcm14248722}
}
Kostenlos starten →